Weiss Asset Management LP[1 »

Protagonist Therapeutics shares owned by Weiss Asset Management LP[1

Quarter-by-quarter ownership of Protagonist Therapeutics (PTGX) shares owned by Weiss Asset Management LP[1 from 13F filings

Historical chart of Weiss Asset Management LP[1 investment in Protagonist Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Protagonist Therapeutics held by Weiss Asset Management LP[1 consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Protagonist Therapeutics by Weiss Asset Management LP[1

Quarter filed Position value Share count Share price at filing
2026-03-31 $1.0M 9.8k 105.40
2025-09-30 $951k 14k 66.43
2024-09-30 $2.8M 63k 45.00

More positions owned by Weiss Asset Management LP[1

NVIDIA Corporation Put Option (NVDA)
Strategy Cl A New (MSTR)
Sprott Asset Management Physical Silver (PSLV)
Strategy Note 0.625% 9/1 (Principal)
Super Micro Computer Note 2.250% 7/1 (Principal)
Nextera Energy Unit 02/15/2029 (NEE.PV)
Theravance Biopharma (TBPH)
Strategy Note 3/0 (Principal)
Ugi Corp Note 5.000% 6/0 (Principal)
Hologic
Ishares Bitcoin Trust Etf Shs Ben Int (IBIT)
Bitmine Immersion Tecnologie Com New (BMNR)
Sprott Asset Management Physical Gold An (CEF)
Strategy Note 0.625% 3/1 (Principal)
Super Micro Computer Note 3.500% 3/0 (Principal)

View all positions for Weiss Asset Management LP[1

Top funds holding Protagonist Therapeutics

BlackRock
Farallon Capital Management
Vanguard Group
UBS Group
Rtw Investments
Vanguard Portfolio Management
State Street Corporation
Wellington Management Company
Henderson Group
Johnson & Johnson
Invesco
Geode Capital Management
Citadel Advisors
Woodline Partners
Bank of America Corporation

View all funds holding Protagonist Therapeutics